Search Results
Biomarker-Driven Frontline Ovarian Cancer Treatment
Brian Slomovitz, MD, on incorporating biomarker-driven therapy in ovarian cancer
Updates in Ovarian Cancer: Frontline Maintenance
Predictive Biomarkers in Ovarian Cancer
Implementing biomarker-driven strategies in RCC
Advanced Ovarian Cancer: Making the Most of Mutations and Biomarkers to Inform Treatment Plans
The Impact of PAOLA-1 on Frontline Treatment of Ovarian Cancer
Frontline Ovarian Cancer Management: Ongoing Clinical Trials
Duration of Frontline Therapy in Ovarian Cancer
Advanced Ovarian Cancer: Making the Most of Mutations and Biomarkers to Inform Treatment Plans
Treatment of HRD-Negative Ovarian Cancer
Advanced Ovarian Cancer: New Insights on Making the Most of Mutations and Biomarkers to Inform
